Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094 · see citing works

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969 · see citing works

Guide for the care and use of laboratory animals

(1997) · Choice Reviews Online · doi:10.5860/choice.34-3310 · Cited by 2,930 · see citing works

Whole genomes redefine the mutational landscape of pancreatic cancer

Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642 · see citing works

Pancreatic adenocarcinoma

Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348 · see citing works

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058 · see citing works

Delivery materials for siRNA therapeutics

Kanasty, R., Dorkin, J. R., Vegas, A., & Anderson, D. (2013) · Nature Materials · doi:10.1038/nmat3765 · Cited by 1,800 · see citing works

RNA-Based Therapeutics: Current Progress and Future Prospects

Burnett, J., & Rossi, J. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.12.008 · Cited by 910 · see citing works

Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers

Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.031 · Cited by 848 · see citing works

The origins and evolution of “controlled” drug delivery systems

Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 740 · see citing works

Pancreatic Cancer

Maitra, A., & Hruban, R. H. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154305 · Cited by 707 · see citing works

First-in-Humans Trial of an RNA Interference Therapeutic Targeting VEGF and KSP in Cancer Patients with Liver Involvement

Tabernero, J. M., Shapiro, G. I., LoRusso, P. M., Cervantes, A. M. R., Schwartz, G. K., Weiss, G. J., Paz-Ares, L. G., Cho, D. C., Infante, J. R., Alsina, M., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0429 · Cited by 700 · see citing works

Transport of Molecules, Particles, and Cells in Solid Tumors

Jain, R. K. (1999) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.1.1.241 · Cited by 691 · see citing works

Biodegradable block copolymers for delivery of proteins and water-insoluble drugs

Zentner, G. M., Rathi, R. C., Shih, C., McRea, J. C., Seo, M.-H., Oh, H., Rhee, B.-O., Mestecky, J. F., Moldoveanu, Z., Morgan, M. E., et al. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00276-0 · Cited by 587 · see citing works

Pancreatic cancer: from state-of-the-art treatments to promising novel therapies

Garrido‐Laguna, I., & Hidalgo, M. M. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.53 · Cited by 565 · see citing works

Oncogenic KRAS signalling in pancreatic cancer

Eser, S., Schnieke, A., Schneider, G., & Saur, D. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.215 · Cited by 504 · see citing works

Pharmacologic rationale for regional drug delivery.

Collins, J. M. (1984) · Journal of Clinical Oncology · doi:10.1200/jco.1984.2.5.498 · Cited by 466 · see citing works

Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA

Zuckerman, J. E., Gritli, I., Tolcher, A. W., Heidel, J. D., Lim, D. W., Morgan, R. J., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 436 · see citing works

Qualitative and Quantitative Analysis of Nonneoplastic Lesions in Toxicology Studies

Shackelford, C. C., Long, G. G., Wolf, J. C., Okerberg, C. V., & Herbert, R. (2002) · Toxicologic Pathology · doi:10.1080/01926230252824761 · Cited by 432 · see citing works

Clinical experiences with systemically administered siRNA-based therapeutics in cancer

Zuckerman, J. E., & Davis, M. E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4685 · Cited by 424 · see citing works

A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response

Onuki, Y., Bhardwaj, U., Papadimitrakopoulos, F., & Burgess, D. J. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200610 · Cited by 417 · see citing works

Engineered polymers for advanced drug delivery

Kim, S., Kim, J., Jeon, O., Kwon, I. C., & Park, K. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.021 · Cited by 355 · see citing works

RNAi therapy targeting KRAS in combination with chemotherapy for locally advanced pancreatic cancer patients

Golan, T., Khvalevsky, E. Z., Hubert, A., Gabai, R. M., Hen, N., Segal, A., Domb, A., Harari, G., David, E. B., Raskin, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4183 · Cited by 336 · see citing works

Mutant KRAS is a druggable target for pancreatic cancer

Zorde Khvalevsky, E., Gabai, R., Rachmut, I. H., Horwitz, E., Brunschwig, Z., Orbach, A., Shemi, A., Golan, T., Domb, A. J., Yavin, E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314307110 · Cited by 295 · see citing works

Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment

Xu, Z., Wang, Y., Zhang, L., & Huang, L. (2014) · ACS Nano · doi:10.1021/nn500216y · Cited by 284 · see citing works

RNAi Therapies: Drugging the Undruggable

Wu, S. Y., Lopez‐Berestein, G., Călin, G. A., & Sood, A. K. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008362 · Cited by 273 · see citing works

Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research

Egusquiaguirre, S. P., Igartúa, M., Hernández, R. M., & Pedraz, J. L. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0766-6 · Cited by 267 · see citing works

First-in-Human Phase I Study of the Liposomal RNA Interference Therapeutic Atu027 in Patients With Advanced Solid Tumors

Schultheis, B. S., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C. M., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 262 · see citing works

Resorbable PLLA-PGA Plate and Screw Fixation in Pediatric Craniofacial Surgery: Clinical Experience in 1883 Patients

Eppley, B. L., Morales, L., Wood, R. J., Pensler, J. M., Goldstein, J., Havlik, R. J., Habal, M. B., D, A. L. M., Williams, J. K., Burstein, F. D., et al. (2004) · Plastic & Reconstructive Surgery · doi:10.1097/01.prs.0000132856.69391.43 · Cited by 251 · see citing works

Delivery systems for siRNA drug development in cancer therapy

Xu, C., & Wang, J. (2014) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.08.011 · Cited by 221 · see citing works

Polymer Implants for Intratumoral Drug Delivery and Cancer Therapy

Weinberg, B. D., Blanco, E., & Gao, J. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21038 · Cited by 159 · see citing works

EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video)

Matthes, K., Mino-Kenudson, M. A., Sahani, D. V., et al. (2006) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2006.06.030 · Cited by 136 · see citing works

Phase 1 study of escalating-dose OncoGel® (ReGel®/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions

Vukelja, S. J., Anthony, S. P., Arseneau, J. C., et al. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328011a51d · Cited by 101 · see citing works

K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment

Réjiba, S., Wack, S., Aprahamian, M., & Hajri, A. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00506.x · Cited by 89 · see citing works

Pancreatic cancer: The microenvironment needs attention too!

Apte, M. V., Xu, Z., Pothula, S. P., Goldstein, D., Pirola, R. C., & Wilson, J. S. (2015) · Pancreatology · doi:10.1016/j.pan.2015.02.013 · Cited by 88 · see citing works

A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors

Tolcher, A. W., Rodrigueza, W. V., Rasco, D. W., Patnaik, A., Papadopoulos, K. P., Amaya, A., Moore, T. D., Gaylor, S. K., Bisgaier, C. L., Sooch, M., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2361-0 · Cited by 88 · see citing works

Pathological and Molecular Evaluation of Pancreatic Neoplasms

Rishi, A., Goggins, M., Wood, L. D., & Hruban, R. H. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.004 · Cited by 77 · see citing works

Biocompatibility studies of naltrexone sustained release formulations

Yamaguchi, K., & Anderson, J. M. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90085-6 · Cited by 72 · see citing works

Medical Device Regulations and Testing for Toxicologic Pathologists

Schuh, J. C. L. (2008) · Toxicologic Pathology · doi:10.1177/0192623307309926 · Cited by 62 · see citing works

Long-term Local and Systemic Safety of Poly( <scp>l</scp> -lactide-co-epsilon-caprolactone) after Subcutaneous and Intra-articular Implantation in Rats

Ramot, Y., Nyska, A., Markovitz, E., Dekel, A., Klaiman, G., Zada, M. H., Domb, A. J., & Maronpot, R. R. (2015) · Toxicologic Pathology · doi:10.1177/0192623315600275 · Cited by 55 · see citing works

Histopathology of biodegradable polymers: challenges in interpretation and the use of a novel compact MRI for biocompatibility evaluation

Nyska, A., Schiffenbauer, Y. S., Tempel-Brami, C., et al. (2014) · Polymers for Advanced Technologies · doi:10.1002/pat.3238 · Cited by 48 · see citing works

Interspecies Differences in Reaction to a Biodegradable Subcutaneous Tissue Filler

Ramot, Y., Touitou, D., Levin, G., Ickowicz, D. E., Zada, M. H., Abbas, R., Yankelson, L., Domb, A. J., & Nyska, A. (2014) · Toxicologic Pathology · doi:10.1177/0192623314534995 · Cited by 33 · see citing works

Multistep, effective drug distribution within solid tumors

Shemi, A., Khvalevsky, E. Z., Gabai, R. M., Domb, A. J., & Barenholz, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5051 · Cited by 30 · see citing works

Endoscopic Ultrasound Guided Antitumor Therapy

Bhutani, M. (2003) · Endoscopy · doi:10.1055/s-2003-41531 · Cited by 28 · see citing works

Endoscopic ultrasound–guided fine-needle injection

Klapman, J. B., & Chang, K. J. (2005) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2004.07.009 · Cited by 28 · see citing works

Challenging the future of siRNA therapeutics against cancer: the crucial role of nanotechnology

Gomes-da-Silva, L. C., Simões, S., & Moreira, J. N. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1502-2 · Cited by 27 · see citing works

Molecular biology of pancreatic cancer

Belda-Iniesta, C., de Cáceres, I. I., Barriuso, J., de Castro, J., Barón, M. G., & Feliú, J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0247-6 · Cited by 26 · see citing works

Safety Evaluation of Medical Devices: US Food and Drug Administration and International Standards Organization Guidelines

NORTHUP, S. J. (1999) · International Journal of Toxicology · doi:10.1080/109158199225431 · Cited by 22 · see citing works

Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial

Davis, J. L., Pandalai, P. K., Ripley, R. T., et al. (2011) · Trials · doi:10.1186/1745-6215-12-129 · Cited by 20 · see citing works

Integration column: Biofunctional polymeric nanoparticles for spatio-temporal control of drug delivery and biomedical applications

Rothenfluh, D. A., & Hubbell, J. A. (2009) · Integrative Biology · doi:10.1039/b907627c · Cited by 15 · see citing works

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery

Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127 · see citing works

Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials

Xie, X., Yu, T., Li, X., Zhang, N., Foster, L. J., Peng, C., Huang, W., & He, G. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01589-z · Cited by 396 · see citing works

Oxidative Stress and Cytokines in the Pathogenesis of Pancreatic Cancer

Yu, J. H., & Kim, H. (2014) · Journal of Cancer Prevention · doi:10.15430/jcp.2014.19.2.97 · Cited by 50 · see citing works

Secreted protein acidic and rich in cysteine inhibits the growth of human pancreatic cancer cells with G1 arrest induction

Mao, Z., Ma, X., Fan, X., Cui, L., Zhu, T., Qu, J., Zhang, J., & Wang, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2315-0 · Cited by 8 · see citing works

Caenorhabditis elegans as a Diagnostic Aid for Pancreatic Cancer

Kobayashi, M., Fujita, A., Ogawa, T., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001814 · Cited by 16 · see citing works

The Role of Exosomes in Pancreatic Cancer

Lan, B., Zeng, S., Grützmann, R., & Pilarsky, C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184332 · Cited by 91 · see citing works

SOX7 expression correlates with better prognosis in pancreatic cancer patients and is negatively related to pancreatic cancer associated diabetes.

Zhou, L., & Kang, M. (2017) · PubMed Central · Cited by 1 · see citing works